CJC-1295 vs IPAMORELIN

Side-by-side comparison of cjc-1295 and ipamorelin. Effects, dosage, side effects, community sentiment, and research.

For informational purposes only. Not medical advice. Always consult a healthcare professional.

Quick Verdict

Muscle IPAMORELIN Both target muscle. IPAMORELIN has a higher community sentiment score (78 vs 70).
Recovery IPAMORELIN Both target recovery. IPAMORELIN has a higher community sentiment score (78 vs 70).
Sleep IPAMORELIN IPAMORELIN is specifically tagged for sleep; CJC-1295 is not.
Stack compatibility

Both target similar goals (Muscle, Recovery) through potentially different mechanisms. Research interactions before stacking.

At a Glance

CJC-1295
Peptide / GH 70/100 Positive 5 studies
MuscleRecovery

CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analog that stimulates growth hormone secretion. It provides sustained GH release and is popular...

VS
IPAMORELIN
Peptide / GH 78/100 Positive 6 studies
MuscleSleepRecovery

Ipamorelin is the most selective GHRP, producing clean GH release without significantly affecting cortisol, prolactin, or appetite. It's considered the 'cleanes...

Detailed Comparison

CJC-1295 IPAMORELIN
Category Peptide, GH Peptide, GH
Sentiment 70/100 (Positive) 78/100 (Positive)
Use Cases Muscle, Recovery Muscle, Sleep, Recovery
Key Effects
  • Increased GH Production: Sustained elevation of growth hormone levels.
  • Improved Sleep: Deeper, more restorative sleep commonly reported.
  • Enhanced Recovery: Faster recovery from workouts and injuries.
  • Clean GH Release: Stimulates GH without affecting other hormones significantly.
  • No Hunger: Unlike other GHRPs, doesn't stimulate appetite.
  • Improved Sleep: Enhanced sleep quality commonly reported.
Dosage
  • Standard Dose: 1-2mg per week, divided into 2-3 injections.
  • Timing: Often injected before bed to complement natural GH pulse.
  • Typical Range: 100-300mcg per injection, 2-3 times daily.
  • Timing: Best on empty stomach, especially before bed.
Side Effects
  • Water Retention: Temporary bloating possible during initial use.
  • Numbness/Tingling: Some users experience paresthesia.
  • Injection Site Reactions: Minor irritation at injection site.
  • Minimal: Fewest side effects of any GHRP.
  • Possible Head Rush: Some experience temporary sensation post-injection.
  • Water Retention: Mild, less than other GHRPs.
Studies 5 published studies 6 published studies

Community Sentiment

CJC-1295

70/100

Users report improved sleep, recovery, and body composition. Often preferred stacked with a GHRP for synergistic GH release. Results take weeks to become noticeable.

IPAMORELIN

78/100

Highly regarded for its clean effects and excellent tolerability. Users prefer it for GH benefits without hunger stimulation or hormonal disruption. Often the recommended starting GHRP.

Research Studies

CJC-1295 (5 studies)

Prolonged stimulation of growth hormone and insulin-like growth factor I secretion by CJC-1295 in healthy adults

CJC-1295 effectively increases growth hormone and IGF-I levels in healthy adults with potential therapeutic utility.

Oxford Academic
Once-daily administration of CJC-1295 normalizes growth in the GHRH knockout mouse

Once-daily CJC-1295 maintains normal body composition and growth in GHRH knockout mice.

American Journal of Physiology
Human growth hormone-releasing factor albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295

CJC-1295 is a stable, active human growth hormone-releasing factor analog with extended plasma half-life.

Oxford Academic
View all CJC-1295 research →

IPAMORELIN (6 studies)

Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers

Study examining how ipamorelin affects hormone levels in healthy males, showing dose-dependent growth hormone release with a short duration.

PubMed
Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients

Testing safety and effectiveness of ipamorelin in treating postoperative ileus after bowel surgery; found well-tolerated but no significant improvement over placebo.

PubMed
Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males

Explores growth hormone secretagogues like ipamorelin as potential therapies for male hypogonadism and improving body composition.

PubMed
View all IPAMORELIN research →

Frequently Asked Questions

Is CJC-1295 or IPAMORELIN better?

Based on aggregated community sentiment, IPAMORELIN has a higher satisfaction score (78/100 Positive) compared to CJC-1295 (70/100 Positive). The better choice depends on your specific goals — review the per-goal comparison above.

Can you take CJC-1295 and IPAMORELIN together?

CJC-1295 and IPAMORELIN are sometimes used together, but safety data on this combination may be limited. Always consult a healthcare professional before combining any compounds. Check our protocols section for researched stacks.

What is the difference between CJC-1295 and IPAMORELIN?

CJC-1295 is a Peptide/GH primarily used for muscle, recovery. IPAMORELIN is a Peptide/GH primarily used for muscle, sleep, recovery. They differ in mechanism of action, dosage protocols, and side effect profiles. See the detailed comparison above.

Which is better for muscle: CJC-1295 or IPAMORELIN?

For muscle, both CJC-1295 and IPAMORELIN are commonly used. Community data suggests IPAMORELIN has higher overall satisfaction (78/100). However, individual responses vary — what works best depends on your specific situation and biochemistry.

Full Compound Profiles

CJC-1295 View full profile → IPAMORELIN View full profile →
← Compare other compounds | + Add a third compound